“Identification of a Papain-Like Protease Inhibitor With Potential for Repurposing in Combination With an Mpro Protease Inhibitor for Treatment of SARS-CoV-2”. 2022. Archives of Clinical and Biomedical Research 6 (6): 993-1002. https://fortunejournals.org/ojs/index.php/acbr/article/view/14979.